If we have selected the wrong experience for you, please change it above.
Great science often speaks to other scientists, not to investors. Deloitte helped to close that gap.
The Challenge
An emerging biotech company had reached a defining moment.
Years of scientific innovation had created a promising portfolio of development assets. Now the company faced a different challenge: turning research into commercial success.
The CEO was preparing to take the company through a critical phase of growth. Strategic decisions about portfolio priorities, organisational readiness and future investment opportunities were becoming increasingly urgent. So too was the need for stronger engagement with the Board and alignment across the leadership team.
The company needed clear direction and leadership alignment, and quickly.
The Solution
- Deloitte worked closely with the CEO and Board through our Executive Transition Lab – an immersive and highly facilitated experience designed to help leaders advance in periods of significant change.
- The lab experience was shaped by a Deloitte team who bring years of biotech industry expertise and leadership advisory experience to the table, not just to facilitate the conversation but also to actively challenge thinking and build strategic blueprints in real time.
- The conversations were candid. The decisions were practical. The outcome was clear.
Leadership transitions are deeply personal. They require trust, candour and the ability to challenge assumptions constructively. We value the confidence our clients place in us and approach every engagement with that responsibility in mind.
- Elsa Torchet.Director, Strategy and Business Design
The Impact
This engagement with Deloitte equipped the CEO with a stronger leadership narrative, enabling him to obtain the backing of the Board and investors for the growth journey he envisioned. Investors knew exactly what was planned and when to expect it. The company was better positioned to pursue future fundraising opportunities and strategic growth initiatives, taking good science to the patients it was designed to serve.
